BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lymphoma AND BCR, FLJ16453, 613, ENSG00000186716, BCR1, D22S662, D22S11, CML, P11274, PHL, ALL
22895 results:

  • 1. A multiomic characterization of the leukemia cell line REH using short- and long-read sequencing.
    Lysenkova Wiklander M; Arvidsson G; Bunikis I; Lundmark A; Raine A; Marincevic-Zuniga Y; Gezelius H; Bremer A; Feuk L; Ameur A; Nordlund J
    Life Sci Alliance; 2024 Aug; 7(8):. PubMed ID: 38777370
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. A retrospective study of an irradiation-based conditioning regimen and chidamide maintenance therapy in T-ALL/LBL.
    Wang X; Deng Y; He G; Lai S; Li Y; Zhang S; He Y; Han Y; Zhang L; Su Y; Liu F; Yi H
    Hematology; 2024 Dec; 29(1):2356300. PubMed ID: 38776229
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. The outcome of relapsed childhood acute lymphoblastic leukemia after allogeneic hematopoietic stem-cell transplantations: A single-center experience.
    Aygüneş U; Karagün BŞ; Şaşmaz I; Antmen AB
    Clin Transplant; 2024 May; 38(5):e15366. PubMed ID: 38775798
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Unraveling resistance mechanisms in anti-CD19 chimeric antigen receptor-T therapy for B-ALL: a novel in vitro model and insights into target antigen dynamics.
    Li H; Wang Y; Liu R; Li X; Zhang P; Chen P; Zhao N; Li B; Wang J; Tang Y
    J Transl Med; 2024 May; 22(1):482. PubMed ID: 38773607
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. A Rare Case of Congenital Nephrogenic Diabetes Insipidus Associated with Aquaporin 2 Gene Mutation and Subsequent Acute Lymphoblastic Leukemia: Impact of Steroids on Kidney Function.
    Al-Thiabat H; Abu-Aqoulah A; Kanaan D; Matalka MI; Al-Sweedan S
    Am J Case Rep; 2024 May; 25():e943597. PubMed ID: 38769718
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Application and prognostic relevance of CD34 detection in immunophenotyping of pediatric acute B lymphoblastic leukemia.
    Zha W; Yuan Y; Yang T; Zhu LJ; Kong WY; Zhuo JJ
    Eur Rev Med Pharmacol Sci; 2024 May; 28(9):3384-3390. PubMed ID: 38766795
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Impact of Fee For Service on the Efficiency and Survival of Seguro Popular's Patients With Acute Lymphoblastic Leukemia in Mexico.
    Cerecero-García D; Macías-González F; Muñoz-Aguirre P; Huerta-Gutierrez R; Zapata M; Rivera-Luna R; Lajous M; Bautista-Arredondo S
    JCO Glob Oncol; 2024 May; 10():e2300060. PubMed ID: 38754053
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Periorbital cellulitis as the initial presentation of acute lymphoblastic leukaemia.
    Han-Menz C; Kozgar SAM; Rana MS
    BMJ Case Rep; 2024 May; 17(5):. PubMed ID: 38749518
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Case report: Preventive infusion of donor-derived CD7 chimeric antigen receptor T cells after allogeneic hematopoietic stem cell transplantation.
    Jiang Y; Feng D; Zhu J; Wei D; Zhao C; Liu H; Shao S; Wang C
    Front Immunol; 2024; 15():1381308. PubMed ID: 38745670
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Constitutional and acquired genetic variants in ARID5B in pediatric B-cell precursor acute lymphoblastic leukemia.
    Ragnarsson C; Yang M; Moura-Castro LH; Aydın E; Gunnarsson R; Olsson-Arvidsson L; Lilljebjörn H; Fioretos T; Duployez N; Zaliova M; Zuna J; Castor A; Johansson B; Paulsson K
    Genes Chromosomes Cancer; 2024 May; 63(5):e23242. PubMed ID: 38738968
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Comprehensive analysis of the efficacy and safety of CAR T-cell therapy in patients with relapsed or refractory B-cell acute lymphoblastic leukaemia: a systematic review and meta-analysis.
    Willyanto SE; Alimsjah YA; Tanjaya K; Tuekprakhon A; Pawestri AR
    Ann Med; 2024 Dec; 56(1):2349796. PubMed ID: 38738799
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Foetal haemoglobin elevation, unfavourable prognosis, and protective role of genetic variants
    Borrayo-LóPez FJ; Ibarra-Cortés B; Perea-Díaz F; MuñOz-Zúñiga AI; Montoya-Fuentes H; Soto-Padilla JM; Rizo-De La Torre LDC
    J Genet; 2024; 103():. PubMed ID: 38736250
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Triple Trouble.
    Diwan A; Barsode S
    J Assoc Physicians India; 2024 Mar; 72(3):97-99. PubMed ID: 38736127
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Valrubicin-loaded immunoliposomes for specific vesicle-mediated cell death in the treatment of hematological cancers.
    Georgievski A; Bellaye PS; Tournier B; Choubley H; Pais de Barros JP; Herbst M; Béduneau A; Callier P; Collin B; Végran F; Ballerini P; Garrido C; Quéré R
    Cell Death Dis; 2024 May; 15(5):328. PubMed ID: 38734740
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Inotuzumab ozogamicin for the treatment of adult acute lymphoblastic leukemia: past progress, current research and future directions.
    Short NJ; Jabbour E; Jain N; Kantarjian H
    J Hematol Oncol; 2024 May; 17(1):32. PubMed ID: 38734670
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. The Evolving Landscape of Flowcytometric Minimal Residual Disease Monitoring in B-Cell Precursor Acute Lymphoblastic Leukemia.
    Verbeek MWC; van der Velden VHJ
    Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38732101
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Frequency and Aberrant CD Marker Profile of Acute Leukaemias.
    Arshad MZ; Hassan MA; Bibi M; Hussain M; Alam M; Riaz MO
    J Coll Physicians Surg Pak; 2024 May; 34(5):539-544. PubMed ID: 38720213
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. [The value of minimal residual disease and IKZF1 deletion for predicting prognosis in adult patients with B-cell acute lymphoblastic leukemia].
    Deng SY; Ou JW; Huang ZC; Chen JJ; Cai ZH; Liu QF; Zhou HS
    Zhonghua Xue Ye Xue Za Zhi; 2024 Mar; 45(3):257-263. PubMed ID: 38716597
    [No Abstract]    [Full Text] [Related]  

  • 19. [Efficacy of allogeneic hematopoietic stem cell transplantation based on a total body irradiation conditioning treatment regimen for adult acute lymphocytic leukemia].
    Xiao QQ; Yu XL; Song XC; Hou YX; Deng L; Li WJ; Zhou F
    Zhonghua Xue Ye Xue Za Zhi; 2024 Mar; 45(3):249-256. PubMed ID: 38716596
    [No Abstract]    [Full Text] [Related]  

  • 20. Intracranial residual lesions following early intensification in a patient with T-cell acute lymphoblastic leukemia: a case report.
    Nagamatsu Y; Isoda T; Inaji M; Oyama J; Niizato D; Tomomasa D; Mitsuiki N; Yamashita M; Kamiya T; Imai K; Kanegane H; Morio T; Takagi M
    BMC Pediatr; 2024 May; 24(1):304. PubMed ID: 38704558
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 1145.